187 related articles for article (PubMed ID: 37694062)
21. Epidemiology, clinical presentation and management of COVID-19 associated mucormycosis: A single centre experience from Pune, Western India.
Dravid A; Kashiva R; Khan Z; Bande B; Memon D; Kodre A; Mane M; Pawar V; Patil D; Kalyani S; Raut P; Bapte M; Saldanha C; Chandak D; Patil T; Reddy S; Bhayani K; Suresh L; Dillibabu V; Srivastava S; Khandelwal S; More S; Shakeel A; Pawar M; Nande P; Harshe A; Kadam S; Hallikar S; Kamal N; Andrabi D; Bodhale S; Raut A; Chandrashekhar S; Raman C; Mahajan U; Joshi G; Mane D
Mycoses; 2022 May; 65(5):526-540. PubMed ID: 35212032
[TBL] [Abstract][Full Text] [Related]
22. Rhino-orbito-cerebral mucormycosis. A retrospective analysis of clinical features and treatment outcomes.
Nithyanandam S; Jacob MS; Battu RR; Thomas RK; Correa MA; D'Souza O
Indian J Ophthalmol; 2003 Sep; 51(3):231-6. PubMed ID: 14601848
[TBL] [Abstract][Full Text] [Related]
23. Fatality Chooses Its Path Through the Orbit: A Study of Rhino-Orbito-Cerebral Mucormycosis as a Complication of COVID-19 Infection.
Mehfooz S; Mehrotra N; Usmani T; Raj V
Cureus; 2022 Nov; 14(11):e31822. PubMed ID: 36579288
[TBL] [Abstract][Full Text] [Related]
24. Combination antifungal therapy without craniotomy in an immunocompromised patient with rhino-orbito-cerebral mucormycosis: A case report.
Salehi M; Shahi F; Rizvi FS; Ghaderkhani S; Zainaldain H; Khodavaisy S; Jamali-Moghaddam SR; Dehghan Manshadi SA; Rezahosseini O
Caspian J Intern Med; 2020; 11(2):227-230. PubMed ID: 32509254
[TBL] [Abstract][Full Text] [Related]
25. Rhino-orbital mucormycosis following COVID-19 in previously non-diabetic, immunocompetent patients.
Nair AG; Adulkar NG; D'Cunha L; Rao PR; Bradoo RA; Bapaye MM; Kothari A; Dave TV; Shinde CA
Orbit; 2021 Dec; 40(6):499-504. PubMed ID: 34338124
[TBL] [Abstract][Full Text] [Related]
26. Rhino-orbital mucormycosis: Our experiences with clinical features and management in a tertiary care center.
Singh SP; Rana J; Singh VK; Singh R; Sachan R; Singh S; Jain S
Rom J Ophthalmol; 2021; 65(4):339-353. PubMed ID: 35087975
[No Abstract] [Full Text] [Related]
27. Clinical Presentations, Management and Outcomes of Rhino-Orbital-Cerebral Mucormycosis (ROCM) Following COVID-19: A Multi-Centric Study.
Dave TV; Gopinathan Nair A; Hegde R; Vithalani N; Desai S; Adulkar N; Kamal S; Mittal R; Bradoo RA
Ophthalmic Plast Reconstr Surg; 2021 Sep-Oct 01; 37(5):488-495. PubMed ID: 34314399
[TBL] [Abstract][Full Text] [Related]
28. Clinical Phenotypes of COVID-19 Associated Mucormycosis (CAM): A Comprehensive Review.
Almyroudi MP; Akinosoglou K; Rello J; Blot S; Dimopoulos G
Diagnostics (Basel); 2022 Dec; 12(12):. PubMed ID: 36553099
[TBL] [Abstract][Full Text] [Related]
29. Managing mucormycosis in diabetic patients: A case report with critical review of the literature.
Beiglboeck FM; Theofilou NE; Fuchs MD; Wiesli MG; Leiggener C; Igelbrink S; Augello M
Oral Dis; 2022 Apr; 28(3):568-576. PubMed ID: 33583133
[TBL] [Abstract][Full Text] [Related]
30. Emergence of Rhino-Orbito-Cerebral Mucormycosis in Peru: Impact of the COVID-19 Pandemic.
Cumpa-Quiroz R; Elguera-Falcón F; Guevara-Lazo DR
Cureus; 2023 Sep; 15(9):e45240. PubMed ID: 37842460
[TBL] [Abstract][Full Text] [Related]
31. Risk factors and outcomes of COVID associated mucormycosis in kidney transplant recipients.
Bansal SB; Rana A; Babras M; Yadav D; Jha P; Jain M; Sethi SK
Transpl Infect Dis; 2022 Apr; 24(2):e13777. PubMed ID: 34932870
[TBL] [Abstract][Full Text] [Related]
32. Orbital Mucormycosis: Understanding the Deadly Fungus Sweeping the Globe.
Farooq S; Khan NA; Singh A; Khan A; Sharma P; Meena R; Jakhar A; Kumar M; Kochar A
Cureus; 2023 Jun; 15(6):e41010. PubMed ID: 37519583
[TBL] [Abstract][Full Text] [Related]
33. An implant-supported prosthetic rehabilitation of a patient with a bilateral subtotal maxillectomy defect secondary to rhino-orbital-cerebral mucormycosis: A clinical report of a graftless approach.
Gaur V; Patel K; Palka L
J Prosthet Dent; 2022 Jul; 128(1):101-106. PubMed ID: 33551135
[TBL] [Abstract][Full Text] [Related]
34. Rhino-Orbito-Cerebral Mucormycosis During the Second Wave of Covid-19: The Indian Scenario.
Bhardwaj R; Sharma A; Parasher A; Gupta H; Sahu S; Pal S
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):3492-3497. PubMed ID: 34786356
[TBL] [Abstract][Full Text] [Related]
35. Rhino-Orbital Cerebral Mucormycosis in a Non-diabetic Patient Following COVID-19 Infection: A Case Report and Literature Review.
Niazi M; Vittorino I; Thwe H; Alam B; Awosika AO; Omole AE
Cureus; 2022 Dec; 14(12):e32884. PubMed ID: 36699798
[TBL] [Abstract][Full Text] [Related]
36. Analysis of COVID-19-associated rhino-orbital-cerebral mucormycosis patients in a tertiary care center in Northern India.
Yadav H; Sen S; Nath T; Mazumdar S; Jain A; Verma P; Gupta P
Indian J Ophthalmol; 2022 Jun; 70(6):2163-2168. PubMed ID: 35648004
[TBL] [Abstract][Full Text] [Related]
37. Rhino-orbito-cerebral mucormycosis during the COVID-19 third wave in 2021: an Egyptian preliminary report from a single tertiary hospital.
Alloush TK; Mansour O; Alloush AT; Roushdy T; Hamid E; El-Shamy M; Shokri HM
Neurol Sci; 2022 Feb; 43(2):799-809. PubMed ID: 34787754
[TBL] [Abstract][Full Text] [Related]
38. Rhino-Orbito-Cerebral Mucormycosis: An Audit.
Saravanam PK; Thattarakkal VR; Arun A
Indian J Otolaryngol Head Neck Surg; 2022 Oct; 74(Suppl 2):2686-2692. PubMed ID: 36452555
[TBL] [Abstract][Full Text] [Related]
39. Post-COVID-19 rhino-orbito-cerebral mucormycosis: a new addition to challenges in pandemic control.
Mitra S; Janweja M; Sengupta A
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2417-2422. PubMed ID: 34309754
[TBL] [Abstract][Full Text] [Related]
40. Spectrum of intracranial complications of rhino-orbito-cerebral mucormycosis - resurgence in the era of COVID-19 pandemic: a pictorial essay.
Kaushik KS; Ananthasivan R; Acharya UV; Rawat S; Patil UD; Shankar B; Jose A
Emerg Radiol; 2021 Dec; 28(6):1097-1106. PubMed ID: 34605991
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
